Understanding the right strategy as an insider for stock sales is a challenge. The author examines peer benchmarking data and suggested guidelines for insider stock sales by CEOs and other biotech executives following their IPOs.
Biotech Insider Stock Sales: Peer Benchmarks And Guidelines
